In addition, although not statistically significant, we have shown that high HRG1β expression correlates to poor survival in bladder cancer patients (Figure 3D), which is in accordance with recent findings in breast cancer showing that HRG1 is a key promoter of tumorigenicity and metastasis (Tsai et al, 2003). This evidence concerns the gene NRG1 and breast carcinoma.